These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 849258)

  • 41. Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine.
    Yu Q; Greig NH; Holloway HW; Brossi A
    J Med Chem; 1998 Jun; 41(13):2371-9. PubMed ID: 9632370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticholinesterase activity of some degradation products of physostigmine.
    Hemsworth BA; West GB
    J Pharm Sci; 1970 Jan; 59(1):118-20. PubMed ID: 5411316
    [No Abstract]   [Full Text] [Related]  

  • 43. Interactions of organophosphorus and related compounds with cholinesterases, a theoretical study.
    Hurley MM; Balboa A; Lushington GH; Guo J
    Chem Biol Interact; 2005 Dec; 157-158():321-5. PubMed ID: 16289061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transferrin-polycation conjugates as carriers for DNA uptake into cells.
    Wagner E; Zenke M; Cotten M; Beug H; Birnstiel ML
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3410-4. PubMed ID: 2333290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between acetylcholine and cholinesterase activity in the brain following organophosphorus cholinesterase inhibitors.
    Awad O
    Arzneimittelforschung; 1972 Nov; 22(11):1926-7. PubMed ID: 4679066
    [No Abstract]   [Full Text] [Related]  

  • 46. [Sensitivity of cholinesterases from various sources to organophosphate inhibitors with S-alkyl radicals of various lengths].
    Kormilitsyn BN; Moralev SN; Khovanskikh AE; Dalimov DN
    Zh Evol Biokhim Fiziol; 2003; 39(5):405-9. PubMed ID: 14689726
    [No Abstract]   [Full Text] [Related]  

  • 47. Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology.
    Macdonald IR; Reid GA; Pottie IR; Martin E; Darvesh S
    J Nucl Med; 2016 Feb; 57(2):297-302. PubMed ID: 26541777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coupling polylysine to glass beads for plasma membrane isolation.
    Jacobson BS; Cronin J; Branton D
    Biochim Biophys Acta; 1978 Jan; 506(1):81-96. PubMed ID: 620023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fractionation of the snake venoms of Cerastes cerastes and Cerastes vipera.
    Hassan F
    Toxicon; 1977; 15(2):170-3. PubMed ID: 854937
    [No Abstract]   [Full Text] [Related]  

  • 50. Role of cholinergic receptors and cholinesterase activity in hemodynamic responses to cocaine in conscious rats.
    Knuepfer MM; Gan Q
    Am J Physiol; 1999 Jan; 276(1):R103-12. PubMed ID: 9887183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Analogs of anabasine as reversible and irreversible inhibitors of choline esterases of different animals].
    Rozengart EV; Basova NE; Suvorov AA
    Zh Evol Biokhim Fiziol; 2006; 42(1):11-8. PubMed ID: 16579523
    [No Abstract]   [Full Text] [Related]  

  • 52. Multiple supramolecular structures formed by interaction of actin with protamine.
    Grazi E; Magri E; Pasquali-Ronchetti I
    Biochem J; 1982 Jul; 205(1):31-7. PubMed ID: 6215033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Binding of reversible spin-labeled inhibitors with an butyrylcholinesterase active center].
    Dorokhov KE; Grigorian GL
    Biofizika; 1986; 31(5):746-51. PubMed ID: 3022829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cholinesterases inhibition studies of biological active compounds from the rhizomes of Alpinia officinarum Hance and in silico molecular dynamics.
    Lee JS; Kim JH; Han YK; Ma JY; Kim YH; Li W; Yang SY
    Int J Biol Macromol; 2018 Dec; 120(Pt B):2442-2447. PubMed ID: 30193916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 10th International Meeting on Cholinesterases. Preface.
    Reiner E;
    Chem Biol Interact; 2010 Sep; 187(1-3):1-2. PubMed ID: 20595049
    [No Abstract]   [Full Text] [Related]  

  • 56. The relationship between cholinesterase activity and brain permeability to barbitone.
    Rosić N; Milosević MP
    Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):302-7. PubMed ID: 6047617
    [No Abstract]   [Full Text] [Related]  

  • 57. [Binding of phosphoorganic cholinesterase inhibitors in rat brain tissue].
    Balashova EK; Pevzner DL; Rozengart VI; Sherstobitov OE; Abduvarkhabov AA
    Ukr Biokhim Zh; 1976; 48(4):460-4. PubMed ID: 982615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation of enantiomers of quinuclidin-3-Ol derivatives and their interactions with human cholinesterases.
    Simeon-Rudolf V; Tomić S; Bosak A; Primozic I; Orsulić M
    Chem Biol Interact; 2005 Dec; 157-158():420-1. PubMed ID: 16429567
    [No Abstract]   [Full Text] [Related]  

  • 59. Stimulation of clonal growth of normal fibroblasts with substrata coated with basic polymers.
    McKeehan WL; Ham RG
    J Cell Biol; 1976 Dec; 71(3):727-34. PubMed ID: 993268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholinesterase inactivation by snake venoms.
    LEE CY; CHANG CC; KAMIJO K
    Biochem J; 1956 Apr; 62(4):582-8. PubMed ID: 13315217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.